Macimorelin Acetate

Modify Date: 2024-01-02 16:44:10

Macimorelin Acetate Structure
Macimorelin Acetate structure
Common Name Macimorelin Acetate
CAS Number 381231-18-1 Molecular Weight 474.555
Density 1.3±0.1 g/cm3 Boiling Point 948.6±65.0 °C at 760 mmHg
Molecular Formula C26H30N6O3 Melting Point N/A
MSDS N/A Flash Point 527.5±34.3 °C

 Use of Macimorelin Acetate


Macimorelin (EP-1572), a GH secretagogue, is an orally active GHSR agonist. Macimorelin stimulates GH release. Macimorelin can be used in the research of adult growth hormone deficiency (AGHD), and Cancer anorexia-cachexia syndrome (CACS)[1][2][3].

 Names

Name 2-amino-N-[(2R)-1-[[(1R)-1-formamido-2-(1H-indol-3-yl)ethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide
Synonym More Synonyms

 Macimorelin Acetate Biological Activity

Description Macimorelin (EP-1572), a GH secretagogue, is an orally active GHSR agonist. Macimorelin stimulates GH release. Macimorelin can be used in the research of adult growth hormone deficiency (AGHD), and Cancer anorexia-cachexia syndrome (CACS)[1][2][3].
Related Catalog
Target

GHSR[1]

In Vivo Macimorelin (5 mg/kg, i.p. twice daily for 2 weeks) decreases the number and duration of seizures in IHKA mouse model[2]. Animal Model: Intrahippocampal kainic acid (IHKA) mouse model[2] Dosage: 5 mg/kg Administration: Intraperitoneal injection (i.p.), twice daily for 2 weeks. Result: Significantly decreased the number and duration of seizures during the treatment period, but had no antiepileptogenic or disease-modifying effect.
References

[1]. Jose M Garcia, et al. Macimorelin as a Diagnostic Test for Adult GH Deficiency. J Clin Endocrinol Metab. 2018 Aug 1;103(8):3083-3093.

[2]. An Buckinx, et al. Translational potential of the ghrelin receptor agonist macimorelin for seizure suppression in pharmacoresistant epilepsy. Eur J Neurol. 2021 Sep;28(9):3100-3112.

[3]. Ali SA, Garcia JM. Randomized clinical trial of the novel oral ghrelin mimetic macimorelin in the treatment of cancer cachexia: study design and preliminary results. Endocr Rev. 2013;34:

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Boiling Point 948.6±65.0 °C at 760 mmHg
Molecular Formula C26H30N6O3
Molecular Weight 474.555
Flash Point 527.5±34.3 °C
Exact Mass 474.237946
PSA 151.88000
LogP 2.64
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.676

 Synonyms

2-Methylalanyl-N-[(1R)-1-formamido-2-(1H-indol-3-yl)ethyl]-D-tryptophanamide
JMV 1843
Macimorelin
UNII-8680B21W73
D-Tryptophanamide, 2-methylalanyl-N-[(1R)-1-(formylamino)-2-(1H-indol-3-yl)ethyl]-
AEZS-130
Macimorelin Acetate